TABLE 1

ARHGEF11 SNPs significantly associated with type 2 diabetes and type 2 diabetes/IGT in the Amish

SNP IDNCBI locationSNP typeMinor alleleMinor allele frequencyLocation (SNP type)T2D vs. NGT
T2D/IGT vs. NGT
POR (95% CI)POR (95% CI)
RS3187878 153717717 A/G 0.19 Exon 41 (3′ UTR) 0.09 1.52 (0.94–2.47) 0.01 1.61 (1.09–2.38) 
RS6676 153717891 C/T 0.20 Exon 41 (3′ UTR) 0.21 1.35 (0.14–12.5) 0.02 1.57 (1.06–2.32) 
RS2275198 153719954 A/G 0.19 Intron 39 0.28 1.31 (0.79–2.16) 0.03 1.54 (1.03–2.30) 
RS945508 153720154 T/C 0.47 Exon 39 (R1467H) 0.04 0.66 (0.44–0.98) 0.17 0.81 (0.59–1.10) 
RS3818807 153722376 A/T 0.20 Intron37 0.22 1.35 (0.17–11.0) 0.02 1.56 (1.06–2.31) 
RS2275199 153722768 C/T 0.20 Exon 36 (N1207N) 0.15 1.44 (0.87–2.37) 0.01 1.69 (1.15–2.50) 
RS2275201 153728111 C/T 0.20 Intron 29 0.18 1.39 (0.85–2.27) 0.02 1.60 (1.07–2.38) 
RS2275202 153734293 C/T 0.05 Intron 22 0.12 0.47 (0.18–1.25) 0.005 0.33 (0.15–0.75) 
RS2275204 153738508 A/G 0.19 Intron 20 0.26 1.34 (1.03–1.74) 0.04 1.52 (1.02–2.28) 
RS1572409 153741849 A/T 0.20 Intron 17 0.12 1.34 (0.83–2.17) 0.03 1.54 (1.04–2.30) 
RS12136088 153754485 G/T 0.23 Intron 8 0.002 1.56 (0.97–2.52) 0.003 1.77 (1.21–2.58) 
RS1336147 153757272 A/G 0.24 Intron 8 0.09 1.48 (0.94–2.34) 0.009 1.63 (1.13–2.37) 
RS1006168 153759971 A/C 0.24 Intron 6 0.03 1.67 (1.05–2.66) 0.01 1.63 (1.13–2.37) 
RS12141806 153761026 A/T 0.23 Intron 6 0.05 1.60 (1.01–2.54) 0.007 1.68 (1.14–2.46) 
RS1007604 153761953 G/T 0.23 Intron 5 0.15 1.39 (0.89–2.17) 0.02 1.54 (1.08–2.22) 
RS1572416 153765127 A/C 0.24 Intron 3 0.08 1.49 (0.93–2.38) 0.009 1.64 (1.14–2.38) 
RS6427339 153767340 C/T 0.42 Intron 2 0.02 1.66 (1.08–2.55) 0.006 1.60 (1.14–2.25) 
RS6427340 153767457 C/T 0.41 Intron 2 0.005 1.82 (1.20–2.70) 0.0008 1.79 (1.27–2.50) 
RS7541702 153767506 C/T 0.23 Intron 2 0.06 1.56 (0.98–2.50) 0.009 1.67 (1.12–2.44) 
RS1572414 153776947 C/T 0.24 Intron 1 0.08 1.49 (0.93–2.38) 0.009 1.64 (1.14–2.38) 
RS884891 153782676 C/T 0.24 Intron 1 0.09 1.47 (0.93–2.38) 0.009 1.61 (1.12–2.33) 
RS822581 153789298 A/G 0.24 Intron 1 0.08 1.49 (0.94–2.34) 0.009 1.63 (1.13–2.37) 
RS703152 153790978 A/G 0.24 Intron 1 0.09 1.48 (0.82–2.67) 0.01 1.61 (1.12–2.32) 
RS822576 153804644 C/T 0.47 Intron 1 0.06 1.45 (0.01–100) 0.01 1.47 (1.08–2.00) 
RS1336146 153815516 C/T 0.47 Intron 1 0.06 1.43 (0.97–2.10) 0.02 1.46 (1.07–1.99) 
RS822570 153820575 A/G 0.47 Intron 1 0.06 1.44 (0.02–127) 0.02 1.46 (1.07–1.99) 
RS822572 153827775 A/G 0.47 Exon 1 (5′ UTR) 0.08 1.40 (0.96–2.06) 0.02 1.45 (1.07–1.97) 
RS861086 153829497 A/G 0.007 5′ Flank 0.113 12.5 (11.1–16.7) 0.01 12.5 (10.0–14.3) 
RS822585 153830278 A/T 0.41 5′ Flank 0.01 1.69 (0.36–8.33) 0.01 1.52 (1.09–2.08) 
RS1750810 153850563 C/G 0.47 5′ Flank 0.07 1.43 (0.005–500) 0.01 1.47 (1.09–2.00) 
SNP IDNCBI locationSNP typeMinor alleleMinor allele frequencyLocation (SNP type)T2D vs. NGT
T2D/IGT vs. NGT
POR (95% CI)POR (95% CI)
RS3187878 153717717 A/G 0.19 Exon 41 (3′ UTR) 0.09 1.52 (0.94–2.47) 0.01 1.61 (1.09–2.38) 
RS6676 153717891 C/T 0.20 Exon 41 (3′ UTR) 0.21 1.35 (0.14–12.5) 0.02 1.57 (1.06–2.32) 
RS2275198 153719954 A/G 0.19 Intron 39 0.28 1.31 (0.79–2.16) 0.03 1.54 (1.03–2.30) 
RS945508 153720154 T/C 0.47 Exon 39 (R1467H) 0.04 0.66 (0.44–0.98) 0.17 0.81 (0.59–1.10) 
RS3818807 153722376 A/T 0.20 Intron37 0.22 1.35 (0.17–11.0) 0.02 1.56 (1.06–2.31) 
RS2275199 153722768 C/T 0.20 Exon 36 (N1207N) 0.15 1.44 (0.87–2.37) 0.01 1.69 (1.15–2.50) 
RS2275201 153728111 C/T 0.20 Intron 29 0.18 1.39 (0.85–2.27) 0.02 1.60 (1.07–2.38) 
RS2275202 153734293 C/T 0.05 Intron 22 0.12 0.47 (0.18–1.25) 0.005 0.33 (0.15–0.75) 
RS2275204 153738508 A/G 0.19 Intron 20 0.26 1.34 (1.03–1.74) 0.04 1.52 (1.02–2.28) 
RS1572409 153741849 A/T 0.20 Intron 17 0.12 1.34 (0.83–2.17) 0.03 1.54 (1.04–2.30) 
RS12136088 153754485 G/T 0.23 Intron 8 0.002 1.56 (0.97–2.52) 0.003 1.77 (1.21–2.58) 
RS1336147 153757272 A/G 0.24 Intron 8 0.09 1.48 (0.94–2.34) 0.009 1.63 (1.13–2.37) 
RS1006168 153759971 A/C 0.24 Intron 6 0.03 1.67 (1.05–2.66) 0.01 1.63 (1.13–2.37) 
RS12141806 153761026 A/T 0.23 Intron 6 0.05 1.60 (1.01–2.54) 0.007 1.68 (1.14–2.46) 
RS1007604 153761953 G/T 0.23 Intron 5 0.15 1.39 (0.89–2.17) 0.02 1.54 (1.08–2.22) 
RS1572416 153765127 A/C 0.24 Intron 3 0.08 1.49 (0.93–2.38) 0.009 1.64 (1.14–2.38) 
RS6427339 153767340 C/T 0.42 Intron 2 0.02 1.66 (1.08–2.55) 0.006 1.60 (1.14–2.25) 
RS6427340 153767457 C/T 0.41 Intron 2 0.005 1.82 (1.20–2.70) 0.0008 1.79 (1.27–2.50) 
RS7541702 153767506 C/T 0.23 Intron 2 0.06 1.56 (0.98–2.50) 0.009 1.67 (1.12–2.44) 
RS1572414 153776947 C/T 0.24 Intron 1 0.08 1.49 (0.93–2.38) 0.009 1.64 (1.14–2.38) 
RS884891 153782676 C/T 0.24 Intron 1 0.09 1.47 (0.93–2.38) 0.009 1.61 (1.12–2.33) 
RS822581 153789298 A/G 0.24 Intron 1 0.08 1.49 (0.94–2.34) 0.009 1.63 (1.13–2.37) 
RS703152 153790978 A/G 0.24 Intron 1 0.09 1.48 (0.82–2.67) 0.01 1.61 (1.12–2.32) 
RS822576 153804644 C/T 0.47 Intron 1 0.06 1.45 (0.01–100) 0.01 1.47 (1.08–2.00) 
RS1336146 153815516 C/T 0.47 Intron 1 0.06 1.43 (0.97–2.10) 0.02 1.46 (1.07–1.99) 
RS822570 153820575 A/G 0.47 Intron 1 0.06 1.44 (0.02–127) 0.02 1.46 (1.07–1.99) 
RS822572 153827775 A/G 0.47 Exon 1 (5′ UTR) 0.08 1.40 (0.96–2.06) 0.02 1.45 (1.07–1.97) 
RS861086 153829497 A/G 0.007 5′ Flank 0.113 12.5 (11.1–16.7) 0.01 12.5 (10.0–14.3) 
RS822585 153830278 A/T 0.41 5′ Flank 0.01 1.69 (0.36–8.33) 0.01 1.52 (1.09–2.08) 
RS1750810 153850563 C/G 0.47 5′ Flank 0.07 1.43 (0.005–500) 0.01 1.47 (1.09–2.00) 

NCBI location is based on Build 35.1. OR > 1.00 denotes that the minor allele is the risk allele, while OR < 1.00 denotes that the major allele is the risk allele. T2D, type 2 diabetes; UTR, untranslated region.

Close Modal

or Create an Account

Close Modal
Close Modal